0000950170-24-038046 Sample Contracts

BINDING MEMORANDUM OF UNDERSTANDING FOR AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT AND TRANSITIONAL MANUFACTURING AND SUPPLY AGREEMENT

Exclusive License Agreement and Transitional Manufacturing and Supply Agreement • March 28th, 2024 • Scynexis Inc • Pharmaceutical preparations

• Contract Type
  Exclusive License Agreement and Transitional Manufacturing and Supply Agreement
• Filed
  March 28th, 2024
• Company
  Scynexis Inc
• Industry
  Pharmaceutical preparations

This Binding Memorandum of Understanding for Amendment to Exclusive License Agreement and Transitional Manufacturing and Supply Agreement (this “Binding MOU”) is entered into as of December 26, 2023 (the “MOU Effective Date”) by and between Scynexis, Inc. (“Scynexis”) and GlaxoSmithKline Intellectual Property (No.3) Limited (“GSK”). Scynexis and GSK may be each referred to herein individually as a “Party” and collectively as the “Parties”.